| Authors: |
Fritsch EF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Burkhardt UE; Accelerating Cancer Immunotherapy Research, Cambridge, Massachusetts., Hacohen N; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. cwu@partners.org.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. |